Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 5—May 2011
Research

Travel-related Dengue Virus Infection, the Netherlands, 2006–2007

Gijs G.G. BaatenComments to Author , Gerard J.B. Sonder, Hans L. Zaaijer, Tom van Gool, Joan A.P.C.M. Kint, and Anneke van den Hoek
Author affiliations: Author affiliations: Public Health Service, Amsterdam, the Netherlands (G.G.G. Baaten, G.J.B. Sonder, J.A.P.C.M. Kint, A. van den Hoek); Academic Medical Centre, Amsterdam (G.G.G. Baaten, G.J.B. Sonder, H.L. Zaaijer, T. van Gool, A. van den Hoek); National Coordination Centre for Traveller’s Health Advice, Amsterdam (G.G.G. Baaten, G.J.B. Sonder)

Main Article

Table 2

Characteristics of travelers with serologic evidence of recent dengue virus infection from a cohort of 1,207 persons who traveled from the Netherlands to developing countries, October 1, 2006–September 30, 2007*

Traveler no.: age, y/sex Country of birth Destination country (region) Previous times traveled to developing country Travel-related signs and symptoms Dengue-like illness Vaccinated against yellow fever IgM-ratio† IgG-ratio†
1: 33/M The Netherlands Philippines (Asia) 2–5 Fever, myalgia, headache, retro-orbital pain, diarrhea Yes Never NA 17.65
2: 62/M Germany Indonesia (Asia) 0 Skin rash, diarrhea No Never 51.79 38.9
3: 64/M The Netherlands Sri Lanka (Asia) >10 Fever, myalgia, arthralgia, head-ache, retro-orbital pain, diarrhea Yes In 1992 NA 28.3
4: 41/M The Netherlands Cambodia, Thailand, Malaysia, Philippines (Asia) >10 None No Never NA 46.27
5: 36/F The Netherlands Thailand, Singapore (Asia) 6–10 Diarrhea No Never 3.34 NA
6: 37/F The Netherlands Indonesia (Asia) 0 Fever, myalgia, headache, retro-orbital pain, skin rash Yes Never 48.66 142.25
7: 28/M The Netherlands Vietnam (Asia) 2–5 None No Never 2.78 NA
8: 27/M The Netherlands India, Nepal (Asia) 2–5 Diarrhea No Never 5.11 NA
9: 68/M The Netherlands Surinam (Latin America) 1 None No In 2000 NA 8.91
10: 26/F The Netherlands Argentina, Bolivia, Brazil, Chili, Uruguay (Latin America) 0 Fever, myalgia, arthralgia, headache, skin rash, diarrhea Yes For this trip NA 26.67
11: 23/F The Netherlands Surinam (Latin America) 1 Skin rash, diarrhea No For this trip NA 72.82
12: 54/F The Netherlands Gambia (Africa) 2–5 Fever, myalgia, arthralgia, head-ache, retro-orbital pain, diarrhea Yes For this trip NA 26.87
13: 27/M The Netherlands Mali, Burkina Faso (Africa) 2–5 Skin rash, diarrhea No In 2000 18.15 NA
14: 52/M The Netherlands Madagascar (Africa) 6–10 Diarrhea No In 1992 8.82 NA

*Ig, immunoglobulin; NA, ratio not available.
†Posttravel to pretravel. If the posttravel sample test results were negative for a type of anti-DENV, the pretravel serum sample was not tested for that type of antibody.

Main Article

Page created: August 08, 2011
Page updated: August 08, 2011
Page reviewed: August 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external